In addition to its Helpline service, Vetlife continued to provide mental health care through its Health Support service.
In 2023, the service facilitated 198 referrals, connecting individuals with mental health care resources.
The charity also provided over £100,000 of financial support to members of the profession who were facing financial hardship.
Trustee Danny Chambers MRCVS said: "Within the veterinary community, there is a profound sense that Vetlife belongs to all of us.
"With over 4000 of our friends and colleagues reaching out for support within just 12 months, we urgently need your assistance to ensure this invaluable service continues.
"By becoming a 'Friend of Vetlife' with a monthly contribution from just £2.10—less than the cost of a cup of coffee—you provide us with a steady, predictable income, enabling us to plan and deliver long-term, consistent support to our veterinary community."
https://www.vetlife.org.uk/become-a-vetlife-member
Invetx specialises in developing protein-based therapeutics for chronic conditions in companion animals, with a focus on monoclonal antibodies (mAbs).
Dechra says these therapies have targeted modes of action and therefore are often more effective, provide an extended duration of activity and have fewer side effects, all of which help to extend and improve the quality of life for companion animals while decreasing the care burden for pet owners.
Jesper Nordengaard, Chief Executive Officer of Dechra, said: "I regard this acquisition as hugely important for Dechra, marking the start of a new chapter in our growth.
"It demonstrates our ambition to create further points of differentiation and relevance with veterinarians and pet owners alike, confidence in our ability to deliver highly innovative new products, and capacity to execute large scale transactions at speed."
Jesper added: “The half-life extension technology developed by Invetx allows for the generation of therapeutics that make treatment of chronic conditions far more convenient for pet owners and veterinarians through improved compliance.
"The pipeline of products currently being developed are all high value potential and will deepen our expertise in core therapeutic areas such as atopic dermatitis and osteoarthritis, allowing for synergistic product development, sales & marketing, and education efforts in the future.”
https://www.invetx.com
The app allows practices to submit results along with cytology and histopathology results in order to help train the AI algorithm and improve its accuracy from an original sensitivity of 85% and negative predictive value of 97%.
Liron Levy-Hirsch, Managing Director of HT Vista, said: “The HT app has provided us with over 700 additional validated scans to analyse this year alone.
"The validation process is well controlled, whereby we use the lab results to tag the scans as benign or malignant and let the algorithm know if it was correct or not.
"The more we train the algorithm the more accurate it becomes, and it is extremely exciting to see the sensitivity increase to 90% and the NPV to 98%.”
HT Vista says the app was developed to meet demand from clinics.
Liron said: "By having a portal to upload lab results alongside the device’s results not only do we further improve the device, but we also increase confidence among our vets and nurses that the device is a reliable tool.
https://ht-vista.uk
Zoetis has announced a supply problem with Equip Artervac, its vaccine against equine viral arteritis
The current inventory of Equip Artervac has an expiry date of March 29, 2023 and the company is not expecting a new batch to be available until the end of September 2023.
Zoetis says it has been working with relevant organisations to implement a plan to mitigate the impact on breeders.
The Thoroughbred Breeders Association has published advice for a blood sampling scheme at: https://www.rossdales.com/news-events/tba-members-equine-vaccine-advice-regarding-disruption-to-supply-of-equip-artervac, but Zoetis highlights that the advice requires action two weeks after the most recent EVA vaccination.
For more information contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0345 300 8034
Dr Mark Johnston, CEO of Vetstream said: “The usage data of Vetlexicon has continually shown us how important the client factsheets are to practices helping clients understand the health and welfare of their animals.
"Whilst most of our subscribers are accepting of the Vetlexicon content in English, the preferred language of many pet owners is not necessarily English, and we wanted to help practices with that.
"So a major new dimension to the new Vetlexicon website is to enable the content to be made available in many European and Asian languages so that when you are viewing a client factsheet, you can instantly see that content in Spanish, French or Korean and then print it out on paper and give to the owners for them to share with friends or family on their return to home; or to print it as a PDF and email it to them.
"Practices have told us that this will be so useful for the relationship with their clients, and so it is great to be able to provide that now.”
The company says it has also improved the interface and functionality of the site and made it mobile phone friendly.
www.vetlexicon.com
The Fear Free movement was founded in 2016 by US veterinary surgeon Dr Marty Becker.
Marty said: “Just like with humans, a pet can’t be optimally healthy unless they’re also happy.
"Fear, anxiety, and stress (FAS) raise the levels of hormones that are destructive to both the body and mind.
"Fear Free uses clinically proven protocols to remove or reduce FAS triggers, it takes steps to mitigate FAS so that the pet feels safe and calm during a veterinary visit.”
Since launch, over 320,000 veterinary professionals, pet professionals, animal welfare communities, and pet owners have registered for Fear Free’s programmes and courses, and Fear Free says it has become the accepted gold standard within North American veterinary practices.
Yvette Rowntree, Clinic Director at Harrison Family Vets in Reading, said: “This accreditation process has taken everything we do to the next level.
"With open and honest team conversations, development of realistic protocols and a subtle change in behaviours to ensure we always put the pet first within a supportive work environment, our entire team has worked hard to achieve this certification.”
Operations Director, Kristie Faulkner, from Harrison Family Vets, said: “Although it was possible for individuals to be Fear Free certified, this is the first time an entire practice has become certified.
"We have worked very closely with the Fear Free team during the past several months to enable detailed inspection and certification to take place, and we now intend for our other practices, in Dudley, Didsbury, Stockton, and Doncaster, to each reach this standard and become officially certified in the immediate future.”
Fear Free’s CEO, Randy Valpy, said: “Harrison Family Vets’ certification is part of the Fear Free expansion into the UK, New Zealand and Australia and we are absolutely thrilled to have the Reading practice as our first UK Fear Free Certified Veterinary Practice.
"We now plan to certify further practices in the UK and support veterinary professionals who have the relevant knowledge and techniques to practise quality medicine, as well as understanding how to develop the utmost consideration for patient’s emotional health as well.”
https://fearfreepets.com
LacriProtect is designed to increase the depth of the tear film in the management of dry eye, during anaesthesia, or in case of irritation.
It contains a carbomer-based formula in individual, resealable single-use pipettes, so that each application is hygienic and free from cross-contamination.
This, says Samaxia, is particularly useful in clinical settings.
Lacri+ contains 0.4% cross-linked sodium hyaluronate and urea, and is designed to hydrate, lubricate and protect the ocular surface.
It comes in a multi-dispense bottle with a tip-seal mechanism and multilayer filtration to ensure sterility and give a shelf life of three months after opening.
https://www.samaxia.com
The successful candidate will be awarded a free place on Improve Veterinary Education’s Emergency and Critical Care Nurse Certificate (NCert) online training programme, which covers:
The 9-module online course also offers optional practical modules which will be included in the scholarship.
Claire L Dorey-Phillips BSc (Hons) VNPA ISFM FNDip RVN, Senior Programme Coordinator at Improve Veterinary Education said: “Similar to Louise, we are deeply committed to mentoring and offering delegates the finest opportunities, ultimately enhancing patient welfare in their care and ensuring optimal outcomes.
"The scholarship grants delegates free enrolment in the Nurse Certificate in Emergency and Critical Care programme, inclusive of complementary RECOVER Initiative responder online modules, online study skill lessons for delegate support, 12-month access to the RCVS knowledge library and a complimentary Emergency and Critical Care textbook which is in conjunction with a dedicated programme coordinator and assessment team to provide pastoral support and guidance when required.”
Applications close on 31st July 2024.
https://subscriptions.improveinternational.com/louise-odwyer-scholarship-2024
Data for 2023 from UK Pet Food research found that around 5% of UK households own a reptile, up from 3.4% in 2022.
The new leaflets have been created using information from the BSAVA Manual of Reptiles and reviewed by Simon Girling, reptile specialist at The Royal Zoological Society of Scotland.
They cover things like housing, feeding, handling, medication and spotting health concerns, and are now available for veterinary nurses to download and print out for clients thinking about getting a reptile.
There are currently leaflets for the following species:
BSAVA members can download the leaflets free from the BSAVA library.
Subscription access for 12 months to BSAVA’s collection of over 170 client information leaflets is available to non-members for £40+VAT here.vet
The sessions will take place in Gallery Suite 17 and are first come, first served.
Dechra will also be sponsoring two equine sessions at LVS:
www.dechra.co.uk/events
Open to all veterinary professionals looking to enhance their knowledge and skills in emergency and critical care, this year's Congress has a lineup of over 30 internationally-renowned speakers and leading clinicians and offers up to 70 hours of CPD.
This year’s keynote speaker is specialist transplant nurse and chair of the UK One Health Coordination Group, Helen Ballantyne, and organisers will also be welcoming veterinary nurse Ken Yagi, formerly program director of the CPR simulation lab at Cornell University, who’ll deliver an update on the new RECOVER (CPR) guidelines being released this year.
Simon Hagley, ECC Specialist and Clinical Director at Vets Now hospital in Manchester said: “We are confident our 2024 programme offers something for everyone, no matter what stage of your ECC career you are at, from students through to specialists and everything in between.
"We listened to delegate feedback from last year’s event, and we have brought back some firm favourites including our ’Controversies’ and ‘Joined Up Thinking sessions’, but we have introduced exciting new streams including 'Catastrophic case conversations'.
“We’ve also we’ve extended the popular nursing streams from last year to span two entire days and lunchtime case presentations from interns across the country are also on the programme.”
https://www.vets-now.com/congress
Taking over from Carl Gorman, Julian says his focus is to continue the work undertaken this year as part of a ‘programme of change’ for BSAVA, that will continue to promote the strong sense of community within the membership and the wider profession.
Speaking at the BSAVA AGM, Julian said: “I am very humbled as I stand here today as your 67th President. It is certainly the pinnacle of my veterinary career, and the greatest honour yet bestowed on me in life.
"We continue to live in exciting times at BSAVA, and as ever, I join a team of utterly amazing staff at Woodrow House.
“I really do believe that the BSAVA will continue to go from strength to strength and will continue to maintain its relevance and position as the indispensable voice of the small animal veterinary profession.”
Julian started volunteering for the BSAVA after his graduation within the Southeastern Regional committee, becoming Chair of the committee after a few years.
He then became part of the BSAVA Education Committee, BSAVA PetSavers Grants Awarding Committee, and was lately part of the Publications Committee.
He then joined the Presidential ladder two years ago as Junior Vice President.
Outside of his volunteering for the BSAVA, he was at Crossways Vets in West Sussex for 17 years, initially as a partner, then as an owner, and finally as a Clinical Director.
He has since stepped down from the practice to devote his time to being BSAVA President this year.
Omniflora paste is designed to provide fast acting support in acute digestive upset or strategically ahead of perceived stressful events such as travel or veterinary appointments.
It contains probiotics, prebiotics, adsorbents, parabiotics, postbiotics, electrolytes and nutrients.
Omniflora tablets are available for animals who resist an oral syringe.
The tablets contain probiotics, prebiotics and adsorbent clay and fibre.
Veterinary nurse and sales manager, Tara Evans, said: “Digestive upset in cats and dogs is common.
"We wanted to provide vets and pet owners with an easy-to-use solution that can be used in practice or at home.
"One tube of paste lasts for three consecutive days to support cats and dogs as they recover from gastrointestinal upset.”
"As well as supporting the gut in acute episodes of digestive upset such as diarrhoea, Omniflora can be used ahead of time in stressful events such as travelling, visiting the groomers, or any planned veterinary procedures such as surgeries or blood tests.”
Omniflora can be ordered here https://www.vitaanimalhealth.com/product/omniflora
Strangvac has been in development for over 25 years and Dechra says it's the first and only intramuscular vaccine to help protect against strangles.
Strangvac contains recombinant proteins CCE, Eq85 and IdeE from Streptococcus equi and has DIVA (Differentiating Infected from Vaccinated Animals) capability.
The vaccine contains no live bacteria or bacterial DNA, so will not trigger positive culture or PCR tests.
In trials the new vaccine protected more than 94% of horses1.
Dechra says it reduces the clinical signs of strangles including a high temperature, coughing, inappetence, difficulty swallowing and changes in demeanour, while also reducing the number of lymph node abscesses.
Strangvac can be given to foals from five months of age and two injections should be given at a four-week interval.
Horses at high risk of Streptococcus equi infection, such as those in livery, should be revaccinated after two months.
Based on measured antibody titres, immunological memory was found in horses following repeated vaccination six months after primary vaccination.
Dr Andrew Waller, chief scientific officer at Intervacc AB, the company that developed the vaccine, said: “Strangvac is a ground-breaking new vaccine which, alongside good stable management and biosecurity procedures, can play a really important role in improving herd immunity and reducing the number of strangles cases in the equine population, thereby preventing major economic loss to the equestrian industry.”
https://www.dechra.co.uk/equine/vaccines
The three companies will now offer their services, which include marketing strategy, brand management, search engine marketing, online advertising, email marketing, webchat, social media copywriting, graphic design and web design under the VetsDigital brand.
Sarah Spinks, Managing Director of VetsDigital, said: "In the pursuit of better animal welfare, we empower animal owners, and bridge the gap between the veterinary professional and the pet parent using the most effective digital channels.
“As one combined company, we become Europe’s leading digital agency that specialises in the veterinary sector. With our current presence in 11 countries, we’ll be able to further develop our network whilst still providing our clients with the same personal service they’ve come to expect and deserve.”
Marcelo Alves, Managing Director of Vet Inflow, will move into the role of Managing Partner for Portugal and Spain at VetsDigital, as the company expands to have bases in both the UK and Portugal.
Will Stirling, who becomes a Managing Partner at VetsDigital, bringing with him 14 years of experience marketing in the veterinary industry, having previously worked with veterinary group YourVets and CVS, said: "The veterinary industry is buzzing with growth and renewal as many parts of veterinary marketing and management move into the digital realm. It’s the perfect time to combine the talents of our 3 teams, so that together we can offer industry-leading digital marketing services to veterinary businesses across the UK and Europe.
For more information, visit: https://vetsdigital.com
The training, which is presented by Nicola Lakeman RVN, consists of seven bite-sized modules covering topics such as:
Kai Crawshaw, Brand Manager at Animalcare, said: "GI cases are among the most frequent reasons pet owners reach out to practices and often, these calls revolve around seeking advice on managing symptoms at home.
"This training will help veterinary receptionists and nurses gain the confidence and knowledge to handle these enquiries and ensure that pet owners receive prompt, accurate guidance."
The training is available on the BVRA website: www.bvra.co.uk.
Photo courtesy: https://depositphotos.com
The researchers say that although increased appetite has been reported as a side effect of many AEDs in veterinary literature, the effect had not been quantified or studied in detail.
To assess the phenomenon in greater detail, the research team analysed food motivation through a validated Dog Obesity Risk Assessment questionnaire created by University of Cambridge1.
The study compared 222 dogs diagnosed with idiopathic epilepsy with a control population of 7,086 healthy dogs.
The survey was designed to determine if epilepsy and AEDs were associated with increased food motivation, weight gain and decreased activity, and to assess if and how caregivers managed weight gain in this population.
The data revealed that dogs with idiopathic epilepsy receiving AEDs had significantly higher food motivation in comparison to healthy dogs – they had increased interest in food, were less selective about food, were more interested in food between meals, and wanted more food than usually offered.
In response, carers of dogs on medication put greater effort into restricting how much their dogs ate, particularly of human food.
Despite this, these dogs had significantly greater fat mass.
More than half of owners of dogs with epilepsy always used treats to administer their dog’s ASD medication (53%) and did not compensate for it by reducing the dog’s main food ration (34%).
Given the epilepsy treatment often involves medication two or three times a day, this has the potential to increase calorie intake substantially, an issue compounded by epileptic dogs also being less active.
The researchers say it's important that vets and nurses advise owners to monitor their dog's weight and help them manage it.
Dr Anna Morros-Nuevo of the University of Cambridge, and primary author of this study, said: "Idiopathic epilepsy, and in particular seizure episodes, have such an overwhelming impact on these dogs' families that side effects such as weight gain often get overlooked, both by vets and the pet's families.
"But unfortunately, obesity has lifelong negative impact on health and quality of life, since it predisposes dogs to suffer from joint problems and respiratory diseases, as well as metabolic disorders and urinary incontinence.
"Obese dogs have also been shown to have a shorter lifespan than dogs with a normal weight.
"While ASD are non-negotiable for many of these dogs, their caregivers and veterinarians should be aware of the lifelong impact of their side effects and manage them carefully.
"We hope these findings will help to increase awareness for both veterinary professionals and dog carers of the side effects of ASD and their impact for the patient."
Reference
The awards fall into two categories, those which you need to be nominated for by other people and those which are also open to self-nomination:
Requiring nomination by another person:
Self-nominations allowed:
The deadline for the 2025 awards is Friday, 13 December 2024.
https://www.rcvs.org.uk/how-we-work/rcvs-honours-awards
The guides have been developed for vet teams to share with their clients and work through together, so that both sides are on the same page about owner values, pet welfare and behaviour, and diagnosis and treatment options.
A member of the veterinary team and the client can then work together to make decisions and provide quality care.
One of the pet owners who helped develop the guides said: “I always get so worked up with vet consultations that I forget half of what they say, or feel like I didn’t tell them enough about my pet’s history.
"If the vet used these guides at my next consult, they would make me feel very at ease indeed!”
Pam Mosedale, Clinical Lead at RCVS Knowledge, said: “These guides offer a simple, actionable way to help deliver contextualised care in practice.
"To get started, run through the questions in the guide with a client, and see how this can help you devise a treatment plan with the information you’ve discovered.
"This helps you gain a fuller understanding of your patient’s care and wellbeing needs and your client’s circumstances and expectations.
"Ultimately, this will assist you in delivering quality care that aligns with the needs and expectations of your clients.”
There are three contextualised care discussion guides:
RCVS Knowledge is encouraging veterinary teams to adapt the guides to meet their individual needs.
https://rcvsknowledge.org/contextualisedcare
COMMENT
Anything which helps clear communication between the owner and vet is surely to be applauded, and if owners are prepared to spend the time completing the pre-consultation guide, it would surely leave less room for error.
However, arguably the greatest cause of friction between owners and vets is cost, and that is something only mentioned fleetingly, in the context of: 'Are there any other factors that may impact on the care of your pet? e.g planned holidays or financial concerns'.
Isn't it time to stop beating around the bush?
Isn't there an opportunity here for greater clarity over the level of spending a client is happy with?
Is there an acceptable form of words here to ascertain whether - regardless of whether they have financial concerns or not - the client is one of those who wants the cheapest solution to the problem, one for whom money is no object, or someone who sits somewhere in the middle?
Wouldn't that be more instructive than almost anything else?
The authors say that whilst it has long been suspected that adverse drug reactions are under-reported, this study is the first to show the scale of the problem, using real data from veterinary clinical records.
For the study, researchers looked for electronic heath records within the Small Animal Veterinary Surveillance Network (SAVSNET) which contained “adverse drug reactions” and “side effects” in the free-text clinical narratives.
The results were then analysed to determine the suspected product, the seriousness and expectedness of the event, and whether the event had been reported to the Veterinary Medicines Directorate or Marketing Authorisation Holders.
Of the 827 cases of suspected adverse drug reactions identified out of a total of 10,565 records reviewed, approximately 90% were not reported.
74% were related to dogs and 70% were listed as “expected” (i.e. already listed in the product information).
The clinical severity of the reaction didn’t appear to impact whether it was reported.
Dr Heather Davies, lead author of the study, said: “As adverse drug reaction reporting rate is directly linked to the regulators ability to mitigate safety issues, this paper is a call to arms encouraging all veterinary professionals to report suspected adverse drug reactions and regulators to make reporting quicker and easier.
"It also the highlights the promise that big real-world data sets hold in enhancing drug safety monitoring processes.”
https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13721
The full BEVA Congress programme is now live and super early bird tickets are available from 4th March, saving member delegates up to £200.
The one medicine thread will run through the medicine and orthopaedics and sports medicine streams as well as feature in the Peter Rossdale Plenary Lecture.
BEVA President Roger Smith said “There is much to learn from the human side as well as from what we do as vets.
"We have invited five human medical experts to make some comparative links with human medicine in their presentations.
"Bringing a different angle in this way will help predict what the future holds and advance what we do in the equine veterinary sphere.”
The full programme includes more than 90 hours of live and on-demand CPD covering almost every aspect of equine medicine, surgery and practice.
The first day will commence with an opening address from Olympic gold medallist Sally Gunnell during which she will share her thoughts on maximising performance.
Other highlights include:
Individual super early bird BEVA members prices are £524 for vets and £144 for vet nurses for all three days (with concessionary available for those in their first three years of graduation or earning less than £25,000).
Day tickets and practice passes are also available.
Super early bird ends on Wednesday 29 May 2024.
www.bevacongress.org
The original TATE elbow replacement was first in clinical use in the 2010s and the revised 3rd generation version is apparently a much-improved implant, something which the clinical evaluation trial should demonstrate.
Andy Moores, head of the joint replacement programme at The Moores Orthopaedic Clinic, said: “Canine elbow replacement can be a game-changer for dogs living with chronic elbow pain but up until this point the elbow replacement systems have not been as reliable as we would like.
"The third-generation TATE implant has been in use with a small number of US surgeons for several years now and the results so far have been very promising.
"We are delighted that Biomedtrix have invited us to join the evaluation trial for this implant and that the RCVS Ethics Review Panel have approved this.
"We look forward to offering this surgery as an option for some of our most painful canine patients.”
www.mooresortho.com
For the study, the RVC interviewed 13 small animal general practitioners, exploring their experience of providing pre-purchase consultations for brachycephalic dogs.
The study revealed a number of barriers to delivering effective pre-purchase consultations and advice about these breeds.
They included limited time and resources, competition for appointment availability, a perception that vets are only there to fix things, public distrust of veterinary surgeons (often over money), fear of damaging vet-client relationships, and the conflicting influence of breeders and the Kennel Club on clients.
Many veterinary surgeons that took part in the research felt that they had little or no power to overcome these barriers which are highly intractable at an individual veterinarian level.
A resulting moral conflict in veterinary surgeons between their perceived ethical and moral responsibilities to animal welfare versus the needs and wants of their clients and businesses was expressed by many vets in the study, and was felt to compromise their professional integrity and autonomy.
The study set out a series of recommendations:
Dr Rowena Packer, Lecturer in Companion Animal Behaviour and Welfare Science at the RVC and lead author of the study, said: “This is the first time that the impact of brachycephaly on the practising veterinary surgeon has been explored.
"Our concerning results highlight the importance of recognising that the brachycephalic crisis is not only negatively impacting animals, but it is affecting human wellbeing too.
“Our study highlights the conflict that vets are experiencing - bound both by their duty of care to their brachycephalic patients, but also to animal welfare at a population level.
"Trying to balance both of these responsibilities in the current working environment is proving very challenging for some, leading to moral distress.
"It is, therefore, essential that we protect the mental wellbeing of vets on this issue as well as from an animal welfare perspective.
“As the brachycephalic crisis continues to prevail, the support of leading veterinary organisations is vital in providing a united voice regarding the known harms of brachycephaly and support in facilitating PPCs to ensure vets are protected, and potential owners are fully informed when it comes to acquiring decisions.”
Dr Dan O’Neill, Assoc Prof of Companion Animal Epidemiology at the RVC and co-author of the study, said:
“Over the past decade, the RVC has generated a vast evidence base revealing the true extent of the serious health issues of dogs with brachycephaly.
"This new study now focuses RVC research towards protecting the wellbeing of practising veterinary surgeons who are also shown as victims of the brachycephalic crisis.
"The clear message here is that we all need to ‘stop and think before buying a flat-faced dog’.”
A team of researchers led by Tim Mair, CVS Equine Veterinary Director and Specialist in both Equine Internal Medicine and Equine Soft Tissue Surgery at Bell Equine Veterinary Clinic, will review 100 cases of colitis in adult horses and 100 controls referred to seven equine veterinary hospitals in the UK: five CVS equine veterinary hospitals as well as Rossdales Equine Hospital and University of Liverpool’s equine hospital.
A set of diagnostic tests on blood and faeces will be performed in these cases.
The laboratory tests will include: small redworm serology, culture and PCR of faeces for Salmonella spp, PCR of faeces for Clostridioides difficile and Clostridium perfringens, ELISA of faeces for toxins of C.difficile and C.perfringens, PCR of faeces for coronavirus.
The clinical features, laboratory results, treatments and outcomes will also be recorded.
Tim said: “Acute colitis accounts for around 5% of admissions to referral hospitals.
"And of those who are referred with it, half will not survive but there is very limited evidence available.
"So it’s vital that we build our evidence-base of this life-threatening condition.
"We hope that the outcomes of our new study will lead to a greater understanding of the causes and better inform veterinary treatment of colitis in UK adult horses.”
The Colitis in Adult Horses study is supported by a research grant from CVS, and funding for the small redworm ELISA will be given from Austin Davis Biologics.
The study started at the beginning of 2024 and the first horses have been recruited.
The results of the study are expected to be published in 2025.
The grants, which are for up to £3,500 per annum, are for students - often from disadvantaged backgrounds - who are embarking on a gateway or main veterinary degree course, possibly as a second degree.
Quadstar's latest grantees are Alicia Guarnieri, who is doing a vet degree at the University of Bristol, and Raluca Magadan, a veterinary nurse from Ireland, who is now on the accelerated graduate course at Bristol University.
She said: “Doing a second degree was never going to be easy.
"However, through help from family and locum vet nurse work, I managed to afford my first three years of vet school and made it into final year.
"This is where the difficulty came, as I had to more than forty hours per week of unpaid rotations work, plus clinical EMS during the holiday breaks, which made it very hard for me to earn the money I needed to afford my final year.
"At times it meant I had under £100 to survive an entire month on, which became a big physical and mental challenge.
“That’s when the Quadstar Foundation stepped in and took a weight off my shoulders by helping to pay off my outstanding university fees and providing some financial security in my final months.
"This has been a huge relief and allowed me to finally enjoy my last year at Bristol.
"I can’t thank everyone at the charity enough.”
In addition to funding and mentoring, The Quadstar Foundation helps its grantees with everything from job applications to revision techniques, as well as any mental health crises and helping them to find a place to live.
Nick, who also runs a property and acquisitions company and Animus Surgical, a pet and vet supplies company, said: “Having worked as a vet for many years before setting up my businesses, I have great industry connections and knowledge.
"So, I’m in the privileged position of being able to help committed students to seize the career opportunities they deserve.”
“My main commercial motivation now is to be able to maintain the funding streams required for these grants.
"It’s surprisingly hard to fundraise for individuals.
"That’s why Animus Surgical has just committed to donating 15% of its profits to the Quadstar Foundation.”
He added: “It’s an enormous privilege to support these inspiring young vets who have had such a hard slog to get past the ever-increasing barriers they face. Barriers that back in our day didn’t exist.”
www.quadstar.org